Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial. (Record no. 14289852)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01907 a2200505 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250514160024.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200310s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1539-3704 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.7326/0003-4819-139-7-200310070-00005 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Lisse, Jeffrey R |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20031027 |
| 245 00 - TITLE STATEMENT | |
| Title | Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Annals of internal medicine |
| Date of publication, distribution, etc. | Oct 2003 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 539-46 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Anti-Inflammatory Agents, Non-Steroidal |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aspirin |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cardiovascular Diseases |
| General subdivision | complications |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cyclooxygenase Inhibitors |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Double-Blind Method |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Therapy, Combination |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Gastrointestinal Diseases |
| General subdivision | chemically induced |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hypertension |
| General subdivision | complications |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lactones |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Naproxen |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Osteoarthritis |
| General subdivision | complications |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prospective Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Sulfones |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Perlman, Monica |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Johansson, Gunnar |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Shoemaker, James R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Schechtman, Joy |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Skalky, Carol S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dixon, Mary E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Polis, Adam B |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mollen, Arthur J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Geba, Gregory P |
| 773 0# - HOST ITEM ENTRY | |
| Title | Annals of internal medicine |
| Related parts | vol. 139 |
| -- | no. 7 |
| -- | p. 539-46 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.7326/0003-4819-139-7-200310070-00005">https://doi.org/10.7326/0003-4819-139-7-200310070-00005</a> |
| Public note | Available from publisher's website |
No items available.